Fact CheckerSign in

NCT05828303CompletedPhase 1

Study of Repotrectinib and CYP450 probe Cocktail in Patients with locally advanced or Metastatic Tyrosine Kinase Inhibitors (TKI)-Pretreated ROS1-Positive Non-small Cell Lung Cancer (NSCLC)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 29 Jan 2025

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
17 (actual)
First submitted
16 Aug 2024
Start date
3 Feb 2025
Lead sponsor
Bristol-Myers Squibb Services Unlimited Company
Diseases
Lung cancer
NCT number
NCT05828303
EU CT number
2024-511030-12-00

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 17
  • 22 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (22)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital del Mar
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital HM Nou Delfos
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital Universitario Fundación Jiménez Díaz
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario Ramón y Cajal
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Clínico San Carlos
Coordinator of this site? Confirm its status
MadridSpainCompleted
Clinica Universidad de Navarra
Coordinator of this site? Confirm its status
MadridSpainCompleted
MD Anderson Cancer Center
Coordinator of this site? Confirm its status
MadridSpainCompleted
Clínica Universidad de navarra
Coordinator of this site? Confirm its status
PamplonaSpainCompleted
Hospital Universitario Quironsalud Madrid
Coordinator of this site? Confirm its status
Pozuelo de AlarcónSpainCompleted
Fundación Instituto Valenciano de Oncología
Coordinator of this site? Confirm its status
ValenciaSpainCompleted
Institut de Cancerologie de L'Ouest
Coordinator of this site? Confirm its status
AngersFranceWithdrawn
Institut Bergonie
Coordinator of this site? Confirm its status
BordeauxFranceWithdrawn
Centre Hospitalier Universitaire Grenoble Alpes
Coordinator of this site? Confirm its status
Grenoble Cedex 9FranceWithdrawn
Centre Hospitalier Regional De Marseille
Coordinator of this site? Confirm its status
MarseilleFranceWithdrawn
Centre Hospitalier Universitaire de Poitiers
Coordinator of this site? Confirm its status
PoitiersFranceWithdrawn
Centre Hospitalier Universitaire de Rennes
Coordinator of this site? Confirm its status
RennesFranceWithdrawn
Centre Hospitalier Universitaire de Nantes
Coordinator of this site? Confirm its status
Saint-HerblainFranceWithdrawn
Centro di Riferimento Oncologico di Aviano
Coordinator of this site? Confirm its status
AvianoItalyCompleted
Ospedale Santa Maria Della Misericordia - Azienda Ospedaliera di Perugia
Coordinator of this site? Confirm its status
PerugiaItalyCompleted
Humanitas Mirasole S.p.A.
Coordinator of this site? Confirm its status
RozzanoItalyCompleted
Centro Ricerche Cliniche di Verona s.r.l.
Coordinator of this site? Confirm its status
VeronaItalyCompleted

This page is information, not medical advice. Discuss any trial with your doctor.